Guenther Gastl

Internal Medicine V, Medical university of innsbruck

Affiliated withMedical university of innsbruck

Research Area

Biography

Guenther Gastl has not added Biography.
If you are Guenther Gastl and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 4	2017

Other Publications

Article	Year
Hepatosplenic gammadelta-T-cell lymphoma with leukemic course after renal transplantation. Human pathology\| PubMed ID: 11957154	2002
Low concentrations of STI571 in the cerebrospinal fluid: a case report. British journal of haematology\| PubMed ID: 12028032	2002
Phenotypic and functional deficiencies of leukaemic dendritic cells from patients with chronic myeloid leukaemia. British journal of haematology\| PubMed ID: 12492578	2003
Increase of regulatory T cells in the peripheral blood of cancer patients. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 12576425	2003
Progressive multifocal leukoencephalopathy after allogeneic stem cell transplantation and posttransplantation rituximab. Transplantation\| PubMed ID: 12883208	2003
Overexpression of epithelial cell adhesion molecule antigen in gallbladder carcinoma is an independent marker for poor survival. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 15131054	2004
Anagrelide for thrombocytosis in myeloproliferative disorders: a prospective study to assess efficacy and adverse event profile. Cancer\| PubMed ID: 15476273	2004
High Ep-CAM expression is associated with poor prognosis in node-positive breast cancer. Breast cancer research and treatment\| PubMed ID: 15567937	2004
CD4+CD25+ regulatory T cells inhibit experimental anti-glomerular basement membrane glomerulonephritis in mice. Journal of the American Society of Nephrology : JASN\| PubMed ID: 15788479	2005
Hodgkin's disease variant of Richter's syndrome in chronic lymphocytic leukaemia patients previously treated with fludarabine. British journal of haematology\| PubMed ID: 15813847	2005
Ovarian carcinoma cells and IL-1beta-activated human peritoneal mesothelial cells are possible sources of vascular endothelial growth factor in inflammatory and malignant peritoneal effusion... Gynecologic oncology\| PubMed ID: 15943987	2005
RNAi-mediated knockdown of P-glycoprotein using a transposon-based vector system durably restores imatinib sensitivity in imatinib-resistant CML cell lines. Experimental hematology\| PubMed ID: 15963852	2005
Dendritic cells from patients with chronic myeloid leukemia: functional and phenotypic features. Leukemia & lymphoma\| PubMed ID: 16019503	2005
The kinase inhibitor imatinib mesylate inhibits TNF-{alpha} production in vitro and prevents TNF-dependent acute hepatic inflammation. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 16174751	2005
The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 16322292	2005
Telomere length of in vivo expanded CD4(+)CD25 (+) regulatory T-cells is preserved in cancer patients. Cancer immunology, immunotherapy : CII\| PubMed ID: 16362412	2006
Methylation status of the Ep-CAM promoter region in human breast cancer cell lines and breast cancer tissue. Cancer letters\| PubMed ID: 16624485	2007
Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancer. Gynecologic oncology\| PubMed ID: 16678891	2006
High EGFR expression predicts poor prognosis in patients with squamous cell carcinoma of the oral cavity and oropharynx: a TMA-based immunohistochemical analysis. Oral oncology\| PubMed ID: 16854613	2007
Synergistic and additive antiproliferative effects on human leukemia cell lines induced by combining acetylenehexacarbonyldicobalt complexes with the tyrosine kinase inhibitor imatinib. Journal of inorganic biochemistry\| PubMed ID: 16908070	2006
The effect of zoledronic acid on the function and differentiation of myeloid cells. Haematologica\| PubMed ID: 16956814	2006
EpCAM expression in squamous cell carcinoma of the oral cavity: frequency and relationship to clinicopathologic features. Oral oncology\| PubMed ID: 17418618	2008
Increased angiogenesis in chronic idiopathic myelofibrosis: vascular endothelial growth factor as a prominent angiogenic factor. Human pathology\| PubMed ID: 17442379	2007
STAT1 activation in squamous cell cancer of the oral cavity: a potential predictive marker of response to adjuvant chemotherapy. Cancer\| PubMed ID: 17559122	2007
Knockdown of PgP resensitizes leukemic cells to proteasome inhibitors. Biochemical and biophysical research communications\| PubMed ID: 17662692	2007
Role of forkhead box protein 3 expression in invasive breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 17906214	2007
Measurement of cyclin E genomic copy number and strand length in cell-free DNA distinguish malignant versus benign effusions. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 17908972	2007
TROP2: a novel prognostic marker in squamous cell carcinoma of the oral cavity. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc\| PubMed ID: 18084248	2008
Possible role for gene expression profiling in predicting responses to conventional or targeted drugs in patients with chronic myeloid leukemia. Leukemia & lymphoma\| PubMed ID: 18398726	2008
Hodgkin lymphoma in Tyrol-a population-based study. Annals of hematology\| PubMed ID: 18846373	2009
The sphingosine 1-phosphate receptor agonist FTY720 potently inhibits regulatory T cell proliferation in vitro and in vivo. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 19692647	2009
GRP-78 secreted by tumor cells blocks the antiangiogenic activity of bortezomib. Blood\| PubMed ID: 19713465	2009
High-dose imatinib improves cytogenetic and molecular remissions in patients with pretreated Philadelphia-positive, BCR-ABL-positive chronic phase chronic myeloid leukemia: first results fro... Haematologica\| PubMed ID: 20145273	2010
Effects of EpCAM overexpression on human breast cancer cell lines. BMC cancer\| PubMed ID: 21281469	2011
Clinical aspects, diagnostic challenges and management of patients with neuroendocrine tumors (NETs). Onkologie\| PubMed ID: 21358221	2011
EpCAM expression in primary tumour tissues and metastases: an immunohistochemical analysis. Journal of clinical pathology\| PubMed ID: 21415054	2011
High-dose imatinib induction followed by standard-dose maintenance in pre-treated chronic phase chronic myeloid leukemia patients--final analysis of a randomized, multicenter, phase III tria... Haematologica\| PubMed ID: 22511495	2012
Low expression of junctional adhesion molecule A is associated with metastasis and poor survival in pancreatic cancer. Annals of surgical oncology\| PubMed ID: 22549289	2012
Phenotype-dependent effects of EpCAM expression on growth and invasion of human breast cancer cell lines. BMC cancer\| PubMed ID: 23110550	2012
EpCAM overexpression prolongs proliferative capacity of primary human breast epithelial cells and supports hyperplastic growth. Molecular cancer\| PubMed ID: 23758908	2013
Transition of idiopathic CD4 + lymphocytopenia into mycosis fungoides? Leukemia & lymphoma\| PubMed ID: 24033108	2014
Loss of membranous expression of the intracellular domain of EpCAM is a frequent event and predicts poor survival in patients with pancreatic cancer. Histopathology\| PubMed ID: 24117877	2014
Medical decision analysis for first-line therapy of chronic myeloid leukemia. Leukemia & lymphoma\| PubMed ID: 24160847	2014
Systematic assessment of decision-analytic models for chronic myeloid leukemia. Applied health economics and health policy\| PubMed ID: 24385259	2014
Expression of EpCAM(MF) and EpCAM(MT) variants in human carcinomas. Journal of clinical pathology\| PubMed ID: 24465008	2014
(68)Ga-DOTATOC PET/CT provides accurate tumour extent in patients with extraadrenal paraganglioma compared to (123)I-MIBG SPECT/CT. European journal of nuclear medicine and molecular imaging\| PubMed ID: 25134670	2015
The side population of ovarian cancer cells defines a heterogeneous compartment exhibiting stem cell characteristics. Oncotarget\| PubMed ID: 25216521	2014
Molecular responses and chromosomal aberrations in patients with polycythemia vera treated with peg-proline-interferon alpha-2b. American journal of hematology\| PubMed ID: 25545244	2015
Marine compounds inhibit growth of multiple myeloma in vitro and in vivo. Oncotarget\| PubMed ID: 25860931	2015
Treg(s) in Cancer: Friends or Foe? Journal of cellular physiology\| PubMed ID: 25913194	2015
Soluble EpCAM levels in ascites correlate with positive cytology and neutralize catumaxomab activity in vitro. BMC cancer\| PubMed ID: 25947366	2015
Drug Transporter-Mediated Protection of Cancer Stem Cells From Ionophore Antibiotics. Stem cells translational medicine\| PubMed ID: 26136502	2015
Ropeginterferon alfa-2b, a novel IFNα-2b, induces high response rates with low toxicity in patients with polycythemia vera. Blood\| PubMed ID: 26261238	2015
Detection of soluble EpCAM (sEpCAM) in malignant ascites predicts poor overall survival in patients treated with catumaxomab. Oncotarget\| PubMed ID: 26296970	2015
Oncotyrol--Center for Personalized Cancer Medicine: Methods and Applications of Health Technology Assessment and Outcomes Research. Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen\| PubMed ID: 26354133	2015
Predominant expression of truncated EpCAM is associated with a more aggressive phenotype and predicts poor overall survival in colorectal cancer. International journal of cancer\| PubMed ID: 26996277	2016
High prevalence of side population in human cancer cell lines. Oncoscience\| PubMed ID: 27226981	2016
Long-term treatment of hairy cell leukemia with interferon-α: still a viable therapeutic option. Memo\| PubMed ID: 27429657	2016
Heterogeneity of Cancer Stem Cells: Rationale for Targeting the Stem Cell Niche. Biochimica et biophysica acta\| PubMed ID: 27751894	2016
Treatment of patients with refractory metastatic cancer according to molecular profiling on tumor tissue in the clinical routine: an interim-analysis of the ONCO-T-PROFILE project. Genes & cancer\| PubMed ID: 28050231	2016